AGT-182-101: A Phase 1 Safety and Dose-Finding Study of a Human Insulin Receptor Monoclonal Antibody-Human Iduronate 2-Sulfatase (IDS) Fusion Protein, AGT-182 in Adult Patients with Mucopolysaccharidosis II (MPS II, Hunter Syn

Project: Research project

Project Details

StatusFinished
Effective start/end date10/1/15 → 10/1/16

Funding

  • ArmaGen, Inc.